Brandon Muncan1, Ashly E Jordan2,3,4, David C Perlman3,5, David Frank2,3, Danielle C Ompad3,6, Suzan M Walters2,3. 1. Renaissance School of Medicine at Stony, Brook University, Stony Brook, NY, USA. 2. Behavioral Science Training Program in Drug Abuse Research, Rory Meyers College of Nursing, New York University, New York, NY, USA. 3. Center for Drug Use and HIV/HCV Research, New York, NY, USA. 4. Graduate School of Public Health and Health Policy, City University of New York, New York, NY, USA. 5. Icahn School of Medicine at Mount Sinai, New York, NY, USA. 6. Department of Epidemiology, New York University School of Global Public Health, New York, NY, USA.
Abstract
Introduction/ Objectives: The incidence of hepatitis C (HCV) infection is rising among people who inject drugs (PWID). Even in the context of known HCV prevention and treatment strategies, some PWID remain unengaged in HCV care. This study aimed to identify and characterize experiences and perceptions of PWID regarding the acceptability and effectiveness of HCV testing and treatment at a local syringe service program (SSP). Methods: A total of 36 PWID participated in semi-structured interviews at an SSP in New York City. Interviews were audio-recorded, transcribed, and coded by three coders, following a constructivist grounded theory approach. Relevant themes were identified as they emerged from the data. Results: Interviews with PWID revealed three themes related to the impact of SSPs on HCV care: (1) non-stigmatizing SSP environments, (2) the role of SSPs in improving HCV knowledge, and (3) acceptability of SSPs as sites for HCV care among PWID. Discussion: This paper contributes to the ongoing understanding that SSPs provide a well-accepted source of HCV services for PWID. Participants believed that SSPs are accessible and effective sites for HCV care, and suggested that stigma among PWID continues to affect receipt of HCV care in traditional settings. Conclusions: Understanding attitudes and beliefs of PWID regarding the effectiveness of SSPs as sites for HCV care is crucial for the development of focused strategies to reduce HCV transmission, and to ultimately achieve HCV elimination. Given this, further research is warranted investigating how best to improve HCV care at harm reduction sites such as SSPs.
Introduction/ Objectives: The incidence of hepatitis C (HCV) infection is rising among people who inject drugs (PWID). Even in the context of known HCV prevention and treatment strategies, some PWID remain unengaged in HCV care. This study aimed to identify and characterize experiences and perceptions of PWID regarding the acceptability and effectiveness of HCV testing and treatment at a local syringe service program (SSP). Methods: A total of 36 PWID participated in semi-structured interviews at an SSP in New York City. Interviews were audio-recorded, transcribed, and coded by three coders, following a constructivist grounded theory approach. Relevant themes were identified as they emerged from the data. Results: Interviews with PWID revealed three themes related to the impact of SSPs on HCV care: (1) non-stigmatizing SSP environments, (2) the role of SSPs in improving HCV knowledge, and (3) acceptability of SSPs as sites for HCV care among PWID. Discussion: This paper contributes to the ongoing understanding that SSPs provide a well-accepted source of HCV services for PWID. Participants believed that SSPs are accessible and effective sites for HCV care, and suggested that stigma among PWID continues to affect receipt of HCV care in traditional settings. Conclusions: Understanding attitudes and beliefs of PWID regarding the effectiveness of SSPs as sites for HCV care is crucial for the development of focused strategies to reduce HCV transmission, and to ultimately achieve HCV elimination. Given this, further research is warranted investigating how best to improve HCV care at harm reduction sites such as SSPs.
Entities:
Keywords:
Cluster; Hepatitis C; Syringe service programs; people who inject drugs; stigma
Authors: Shelley N Facente; Rachel Grinstein; Roberta Bruhn; Zhanna Kaidarova; Erin Wilson; Jennifer Hecht; Katie Burk; Eduard Grebe; Meghan D Morris Journal: PLoS One Date: 2022-05-11 Impact factor: 3.752
Authors: Sarah Gutkind; Laura E Starbird; Sean M Murphy; Paul A Teixeira; Lauren K Gooden; Tim Matheson; Daniel J Feaster; Mamta K Jain; Carmen L Masson; David C Perlman; Carlos Del Rio; Lisa R Metsch; Bruce R Schackman Journal: Drug Alcohol Depend Date: 2022-01-10 Impact factor: 4.852
Authors: Suzan M Walters; David Frank; Brent Van Ham; Jessica Jaiswal; Brandon Muncan; Valerie Earnshaw; John Schneider; Samuel R Friedman; Danielle C Ompad Journal: AIDS Behav Date: 2021-10-09
Authors: Rebecca S Bolinski; Suzan Walters; Elizabeth Salisbury-Afshar; Lawrence J Ouellet; Wiley D Jenkins; Ellen Almirol; Brent Van Ham; Scott Fletcher; Christian Johnson; John A Schneider; Danielle Ompad; Mai T Pho Journal: Int J Environ Res Public Health Date: 2022-02-16 Impact factor: 3.390
Authors: Suzan M Walters; Rebecca S Bolinski; Ellen Almirol; Stacy Grundy; Scott Fletcher; John Schneider; Samuel R Friedman; Lawrence J Ouellet; Danielle C Ompad; Wiley Jenkins; Mai T Pho Journal: Addict Sci Clin Pract Date: 2022-04-25
Authors: Kiana Yazdani; Katerina Dolguikh; Wendy Zhang; Sara Shayegi-Nik; Jessica Ly; Shaughna Cooper; Jason Trigg; Sophia Bartlett; Rolando Barrios; Julio S G Montaner; Kate Salters Journal: PLoS One Date: 2022-03-23 Impact factor: 3.240
Authors: Suzan M Walters; Joey Platt; Amarachi Anakaraonye; Sarit A Golub; Chinazo O Cunningham; Brianna L Norton; Jae M Sevelius; Oni J Blackstock Journal: AIDS Behav Date: 2021-06-17